Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
Tech CoreMap raises $37m in Medtronic-led financing roundBy Healthcare Propulsion StaffJuly 30, 20260 CoreMap’s electrophysiology mapping system is under development to provide clinicians with more personalised patient insights when conducting atrial fibrilation ablation…